Sorafenib: all 509 studies that test it
Page 4 of 6. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B CirrhosisCompletedNCT01357486Phase 2
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Sorafenib in Elderly Patients With Metastatic Renal Cell CarcinomaTerminatedNCT01342627Phase 2
- Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)TerminatedNCT01337492Early Phase 1
- Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT01335074Phase 1/2
- Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryStatus unknownNCT01324076Phase 3
- Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line TreatmentCompletedNCT01320111Phase 2
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaActive, not recruitingNCT01303341Phase 1
- Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain MetastasesCompletedNCT01276210Phase 1
- Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneStatus unknownNCT01263951Phase 2
- Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based TreatmentCompletedNCT01262482Phase 2
- Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCCStatus unknownNCT01259193Phase 2
- Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the BladderStatus unknownNCT01222676Phase 2
- Sorafenib in Urothelium Cancer of BladderTerminatedNCT01215266Phase 2
- Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCCStatus unknownNCT01214343Phase 3
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATECompletedNCT01187212Phase 2
- Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerActive, not recruitingNCT01187199Phase 1
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by SurgeryStatus unknownNCT01182272Phase 2
- Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01170104Phase 2
- Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction ChemotherapyTerminatedNCT01159327Phase 2
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01159301Phase 1
- Sorafenib. ICORG 06-41, V4CompletedNCT01158287Phase 2
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerActive, not recruitingNCT01141309Phase 2
- Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01135056Phase 3
- Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular CarcinomaCompletedNCT01131689Phase 1
- Sorafenib Plus S-1 in Advanced Solid TumorsCompletedNCT01128998Phase 1
- Sorafenib for Imatinib/Sunitinib-failed GISTCompletedNCT01091207Phase 2
- An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaCompletedNCT01078961Phase 1
- Sorafenib and Vorinostat in Treating Patients With Advanced Liver CancerCompletedNCT01075113Phase 1
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01047891Phase 2
- Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
- A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaStatus unknownNCT01041482Phase 2
- AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
- Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01011010Phase 1
- Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
- Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver CancerStatus unknownNCT00999843Phase 1/2
- Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant PatientsCompletedNCT00997022Phase 1
- Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationCompletedNCT00989469Phase 1/2
- The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid TumorsCompletedNCT00984425Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
- Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
- Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)CompletedNCT00956436Phase 1
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
- Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00949182Phase 2
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
- 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT00943449Phase 2
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
- Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion ChemotherapyCompletedNCT00933816Phase 1/2
- Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase InhibitorCompletedNCT00922584Phase 2
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNCT00908167Phase 1
- Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of AgeCompletedNCT00893373Phase 2
- Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)CompletedNCT00892658Phase 1
- Sorafenib-RT Treatment for Liver Metastasis (SLIM)CompletedNCT00892424Phase 1/2
- Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal CancerTerminatedNCT00889343Phase 2
- Sorafenib in Relapsed High Grade OsteosarcomaCompletedNCT00889057Phase 2
- Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid CarcinomaCompletedNCT00887107Phase 2
- XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00882869Phase 1/2
- Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)CompletedNCT00875745Phase 1
- Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by SurgeryCompletedNCT00874874Phase 2
- Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryTerminatedNCT00873002Phase 1
- A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
- Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00870532Phase 1
- External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00869570Phase 1/2
- To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.CompletedNCT00861419Phase 1
- First Line Hepato Cellular Carcinoma (HCC)CompletedNCT00858871Phase 3
- Study of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00848640Phase 2
- Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular CarcinomaCompletedNCT00846131Phase 1
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantCompletedNCT00844168Phase 1
- Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentStatus unknownNCT00839111Phase 2
- Hepatic Impairment StudyCompletedNCT00829231Phase 1
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)TerminatedNCT00823290Phase 1
- Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue SarcomaCompletedNCT00822848Phase 1
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00811759Phase 1/2
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
- Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyStatus unknownNCT00801385Phase 2
- Sorafenib in Previously Treated Malignant MesotheliomaStatus unknownNCT00794859Phase 2
- Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and DacarbazineCompletedNCT00794235Phase 2
- Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
- Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
- Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00788099Phase 1
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsStatus unknownNCT00786110Phase 2
- RDEA119 and Sorafenib Combination Dose Escalation StudyCompletedNCT00785226Phase 1/2
- Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal CancerCompletedNCT00780169Phase 1
- Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to ChemotherapyStatus unknownNCT00772694Phase 2
- Sorafenib and Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT00768937Phase 1/2
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and CirrhosisTerminatedNCT00767468Phase 1
- Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast CancerStatus unknownNCT00764972Phase 1/2
- PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid TumorsCompletedNCT00759928Phase 1
- Metastatic Advanced Pancreas SorafenibStatus unknownNCT00758381Phase 2
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
- Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaTerminatedNCT00734526Phase 1